Site-specific immune suppression with topical cyclosporine. Synergism with combined topical corticosteroid added during the maintenance phase.
Llull
R
R
Department of Surgery, University of California, Irvine 92717, USA.
Lee
T P
TP
Vu
A N
AN
Black
K S
KS
Hewitt
C W
CW
D000276:Adjuvants, Immunologic / Q000494:pharmacology; D000287:Administration, Topical; D000305:Adrenal Cortex Hormones / Q000494:pharmacology; D000818:Animals; D000917:Antibody Formation; D016572:Cyclosporine / Q000008:administration & dosage*; D004357:Drug Synergism; D006085:Graft Survival / Q000187:drug effects; D006854:Hydrocortisone / Q000494:pharmacology; D008297:Male; D051381:Rats; D011914:Rats, Inbred BN; D011917:Rats, Inbred Lew; D016038:Skin Transplantation / Q000276:immunology*; D013997:Time Factors
D000276:Adjuvants, Immunologic; D000305:Adrenal Cortex Hormones; D016572:Cyclosporine; D006854:Hydrocortisone